Journal List > Lab Med Online > v.2(3) > 1057158

Lim, Kim, Koo, and Kwon: Evaluation of the Performance of ARKRAY ADAMS HA-8180 HbA1c Analyzer

Abstract

Background

Hemoglobin (Hb)-A1c is routinely used for the management of diabetes. In 2010, HbA1c was included into the diagnostic criteria for diabetes by the American Diabetes Association. A newly developed HbA1c analyzer, ARKRAY ADAMS HA-8180 (ARKRAY KDK, Japan) was introduced. In this study, we evaluated the analytical performance of ARKRAY ADAMS HA-8180 HbA1c analyzer and compared it with the previously used Variant II Turbo (Bio-Rad Laboratories, USA), which is a National Glycohemoglobin Standardization Program (NGSP) certified analyzer.

Methods

According to Clinical Laboratory and Standards Institute (CLSI) evaluation protocol (EP) 5-A, Lyphochek Diabetes Controls (Bio-Rad Laboratories, USA) are used for precision. Two (low and high) levels of quality control materials were analyzed twice a day for 20 days, after which the mean, total standard deviation (SD) and total coefficient of variation (CV), including the between-run CV and between-day CV were calculated. ARKRAY ADAMS HA-8180 HbA1c analyzer and Variant II Turbo were compared with 150 samples according to CLSI EP9-A2. In addition, the linearity and carry over rate were evaluated.

Results

Between-run CVs for low and high level quality control materials were 0.0% and 0.3%, respectively, whereas between-day CVs for low and high level quality control materials were 0.3% and 0.2%, respectively. In the linearity test, the coefficient of determination (R2) was 0.99 (range, 3.1-19.3%). Thus, a good correlation was observed between ARKRAY ADAMS HA-8180 HbA1c analyzer and Variant II Turbo (R2=0.994). The carry over rate was 0.0%.

Conclusions

The ARKRAY ADAMS HA-8180 HbA1c analyzer showed excellent precision, linearity, and carryover rate. It also showed excellent correlation with the NGSP certified Variant II Turbo. In conclusion, the ARKRAY ADAMS HA-8180 HbA1c analyzer is a reliable high-performance liquid chromatography (HPLC) analyzer for HbA1c analysis and could be very useful for the diagnosis, treatment, monitoring, and risk assessment of diabetes.

Figures and Tables

Fig. 1
Comparison of HbA1c levels assayed by Variant II Turbo and ARKRAY ADAMS HA-8180 HbA1c analyzer. (A) Scattered plot with ordinary linear fit (blue line). (B) Bland-Altman difference plot. (C) Bland-Altman % difference plot.
lmo-2-126-g001
Fig. 2
Linearity of HbA1c values using ARKRAY ADAMDS HA-8180 HbA1c analyzer.
lmo-2-126-g002
Table 1
Precision of HbA1c measurement of ARKRAY ADAMDS HA-8180
lmo-2-126-i001

Notes

This article is available from http://www.labmedonline.org

References

1. Peterson KP, Pavlovich JG, Goldstein D, Little R, England J, Peterson CM. What is hemoglobin A1c? An analysis of glycated hemoglobins by electrospray ionization mass spectrometry. Clin Chem. 1998. 44:1951–1958.
crossref
2. Sung YA. HbA1c for diagnosis of type 2 diabetes in Korea. Korean J Med. 2011. 80:288–290.
3. Little RR, Rohifing CL, Tennill AL, Connolly S, Hanson S. Effects of sample storage conditions on glycated hemoglobin measurement: evaluation of five different high performance liquid chromatography methods. Diabetes Technol Ther. 2007. 9:36–42.
crossref
4. Tapp RJ, Tikellis G, Wong TY, Harper CA, Zimmet PZ, Shaw JE, et al. Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Diabetes Care. 2008. 31:1349–1354.
5. American Diabetes Association. Standards of medical care in diabetes 2010. Diabetes Care. 2010. 33:Suppl 1. S11–S61.
6. Kim T, Kim S, Chang HE, Song SH, Park KU, Song J, et al. Performance evaluation of HbA1c test on the Toshiba 200FR NEO using AutoLab HbA1c reagent. J Lab Med Qual Assur. 2010. 32:217–223.
7. Clinical and Laboratory Standards Institute. CLSI document EP5-A2. Evaluation of precision performance of quantitative measurement methods; approved guideline. 2004. 2nd ed. Wayne, PA: Clinical and Laboratory Standards Institute.
8. Clinical and Laboratory Standards Institute. CLSI document EP9-A2. Method comparison and bias estimation using patient samples; approved guideline. 2002. 2nd edition. Wayne, PA: Clinical and Laboratory Standards Institute.
9. Clinical and Laboratory Standards Institute. CLSI document EP6-A2. Evaluation of the linearity of quantitative measurement procedures; a statistical approach. Approved guideline. 2003. Wayne, PA: Clinical and Laboratory Standards Institute.
10. International Diabetes Federation. Diabetes Atlas. 2003. 2nd ed. Belgium: International Diabetes Federation;17–71.
11. Park IB, Baik SH. Epidemiologic characteristics of diabetes mellitus in Korea: Current status of diabetic patients using Korean health insurance database. Korean Diabetes J. 2009. 33:357–362.
crossref
12. American Diabetes Association. Screening for type2 diabetes. Diabetes Care. 2004. 27:Suppl 1. S11–S14.
13. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997. 20:1183–1197.
14. Yun WJ, Shin MH, Kweon SS, Park KS, Lee YH, Nam HS, et al. A comparison of fasting glucose and HbA1c for the diagnosis of diabetes mellitus among Korean adults. J Prev Med Public Health. 2010. 43:451–454.
crossref
15. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010. 33:Suppl 1. S62–S69.
16. Jeppsson JO, Kobold U, Barr J, Finke A, Hoelzel W, Hoshino T, et al. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med. 2002. 40:78–89.
crossref
17. Song J, Kwon KC, Kim JH, Kim JW, Min WK, Lee SY, et al. Annual report on external quality assessment in metabolic disorders in Korea (2009). J Lab Med Qual Assur. 2010. 32:131–146.
18. Park HD, Kim HJ, Kim MS, Lee SY, Kim JW. Evaluation of hemoglobin A1c on the Cobas Integra 800 immunoassay and Tosoh HLC-723 G8 HPLC analyzer. J Lab Med Qual Assur. 2009. 31:239–246.
19. Thevarajah TM, Nani N, Chew YY. Performance evaluation of the Arkray Adams HA-8160 HbA1c analyser. Malays J Pathol. 2008. 30:81–86.
20. Sofronescu AG, Williams LM, Andrews DM, Zhu Y. Unexpected hemoglobin A1c results. Clin Chem. 2011. 57:153–156.
TOOLS
Similar articles